Volume 7, Number 1—February 2001
Synopsis
Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human Isolates
Jørgen Engberg*
, Frank M. Aarestrup†, Diane E. Taylor‡, Peter Gerner-Smidt*, and Irving Nachamkin§
, Frank M. Aarestrup†, Diane E. Taylor‡, Peter Gerner-Smidt*, and Irving Nachamkin§Table 2
Erythromycin and azithromycin resistance rates (%) in Campylobacter in humans, worldwide, since 1989
| Country | C. jejuni | C. coli | C. jejuni and | Ref. |
|---|---|---|---|---|
| C. coli | ||||
| Austria | 0.7 | 5.5 | <1-1.4 | (58 & pers. comm.a) |
| Canada | 0-3.3 | - | - | (59,60) |
| Denmark | 0 | 14.0 | 0-4 | (24,61,62) |
| Finland | - | - | <1-3 | (43,63, & pers. comm.b) |
| France | 1.1 | 12.2 | 3.5 | (64) |
| Hungary | - | - | 0 | (65) |
| Italy | 1.2-6 | 16-68.4 | 7.8-11.6 | (66-69) |
| Japan | 0.8 | - | - | (66) |
| New Zealand | - | - | 1.5 | (70) |
| Singapore | - | - | 51 | (71) |
| Spain | 0-11.0 | 0-35.0 | 3.2-7.3 | (17,27,56,57,72) |
| Sweden | 6.4c | 11.1c | 7.3c | (44) |
| Taiwan | 10.0 | 50.0 | 18.3 | (31) |
| Thailand | - | - | 0-31.0 | (73,74) |
| United Kingdom | 1 | 13 | 1.8 | (75) |
| United States | 0-7.8 | - | - | (10,76-78 & unpub. datad) |
aG Feierl, 2000, pers. comm.
bH Rautelin, 1999, pers. comm.
c90% of isolates were acquired abroad.
dI Nachamkin, 2000, unpub. data.
